bioventrix

Register to receive a free Europe Market for Interventional Cardiology Devices report synopsis and brochure

BioVentrix, Inc. recently announced the first closed-chest Revivent TC™ TransCatheter Ventricular Enhancement System procedure in Germany since receiving CE mark certification. The Less Invasive Ventricular Enhancement™ or LIVE™ procedure was performed by interventional cardiologists Dr. Christian Frerker, MD and Dr. Tobias Schmidt, MD and by cardiothoracic surgeon Dr. Ralf Bader, MD at Asklepios Klinik St. Georg in Hamburg, Germany. The St. Georg Heart team is led by Prof. Dr. Karl-Heinz Kuck, who is also the Chairman of the Department of Cardiology and Electrophysiology.

The physicians implanted 2 anchor pairs and achieved a left ventricular volume reduction of 24%, which is a significant improvement for a patient suffering from ischemic heart failure. Left Ventricular volume reduction is a common measure of cardiac performance that significantly impacts the short and long-term survival rates. By remodeling the LV to a more normal shape and size, the implant improves pumping efficiency, decreases wall stress, and immediately reverses patient symptoms.

“We are pleased to be the first center in Germany to perform the Revivent TC procedure after CE mark certification,” said Dr. Frerker. “The Revivent TC procedure continues to show significant clinical benefits to patients who suffer from ischemic cardiomyopathy post-myocardial infarction. It’s a viable solution when guideline directed medical therapy (GDMT) is not suitable,” continued Dr. Frerker.

 

“The 24% volume reduction should directly impact the heart’s pumping efficiency, which is a positive outcome for ischemic patients. That will result in an improvement in the patient’s quality of life,” added Dr. Schmidt. “This is the only minimally invasive technology which enables plication of scar tissue resulting in complete exclusion outside the LV cavity,” continued Dr. Schmidt.

 

“The Revivent TC procedure alleviates wall stress by the reshaping of the left ventricle and allowing for the heart to operate as it was intended to going forward. The immediate impact the Revivent TC procedure has on a patient is life-changing,” added Dr. Bader.

For Further Information
More on the interventional cardiology device market in Europe can be found in the report published by iData entitled Europe Market for Interventional Cardiology. This report covers drug-eluting stents, bare-metal stents, bioabsorbable stents, PTCA balloons, drug-eluting balloons, interventional catheters and guidewires, diagnostic catheters and guidewires, coronary introducer sheaths, embolic protection devices, atherectomy devices, intravascular ultrasound (IVUS) catheters and optical coherence tomography (OCT) catheters.

The iData series on the market for interventional cardiology devices covers the U.S., Asian Pacific, Brazil, and 15 countries in Europe encompassing Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Full reports also provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about European interventional cardiology market data or procedure data, register online or email us at [email protected] for a Europe Market for Interventional Cardiology report brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

About Reimbursement Tracker
iData Research’s Reimbursement Policy Tracker enables medical device, dental, pharmaceutical and healthcare professionals to receive real-time policy updates from hundreds of insurance companies and 60,000+ policies across all therapeutic areas in the United States.

About iData Research
iData Research (www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Vascular Access, Endoscopy, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics, Ophthalmics, Dental Operatory Equipment and more.


Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Like us on Facebook: facebook.com/iDataResearch
Follow us on LinkedIn: linkedin.com/company/idata-research
Follow us on Twitter: twitter.com/iDataResearch